Onconic Therapeutics (476060.KQ) Earnings Analysis
Onconic Therapeutics (476060.KQ) has no confirmed upcoming earnings date. Trailing P/E 25.88.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 476060.KQ next report earnings?
No confirmed upcoming earnings date is currently scheduled for 476060.KQ. This page updates as the calendar is published.
476060.KQ earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-10 | 143.12 KRW | n/a | n/a | n/a |
| 2026-02-02 | 104.72 KRW | n/a | n/a | n/a |
| 2025-10-30 | 212.4 KRW | n/a | n/a | n/a |
476060.KQ valuation and analyst view
| Trailing P/E | 25.88 |
|---|---|
| Trailing EPS | 453.03 KRW |
| Price / book | 6.52 |
| Dividend yield | 0.00% |
| Market cap | 121.29B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Onconic Therapeutics (476060.KQ)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 476060.KQ. This page updates as the calendar is published.
Did 476060.KQ beat earnings last quarter?
Consensus estimate data was not available for 476060.KQ's 2026-05-10 report.
What is 476060.KQ's current P/E ratio and EPS?
476060.KQ trades at a trailing P/E of 25.88 on trailing EPS of 453.03252444966085 KRW.
What do analysts rate 476060.KQ?
476060.KQ has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.